Analysis: Capitol Hill drug pricing reform opponents among the biggest beneficiaries of pharma funds

Democratic Party lawmakers holding up proposed drug pricing reforms are among the largest beneficiaries of the pharmaceutical industry’s push to stave off price cuts, a Reuters analysis of public lobbying and campaign data shows. The industry, which traditionally gives more to Republicans, channeled around 60% of donated campaign funds to Democrats this year. It has spent over $177 million on lobbying and campaign donations in 2021.

Read the source article at canadanewsmedia.ca
2021-10-26 05:12:08